Sun, 07th Feb 2021 18:58
JOHANNESBURG, Feb 7 (Reuters) - South Africa will suspend
use of the AstraZeneca vaccine in its immunisation
programme while scientists advise on the best way to proceed,
Health Minister Zweli Mkhize said on Sunday.
Mkhize was speaking after trial data showed the AstraZeneca
vaccine offered only limited protection against mild disease
caused by the 501Y.V2 coronavirus variant first identified in
South Africa.
(Reporting by Alexander Winning and Olivia Kumwenda-Mtambo)
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...
(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...
(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...
April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...
(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:
Astrazeneca (AZN)